VOLITIONRX LTD (VNRX)
AMEXHealth CareMedical - DevicesSnapshot 2026-09-04
$0.35-0.09%
Close 2026-09-04 · 1-day change
AMEXHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · VNRX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 2.5 | 1.7 | 1.2 | 0.8 | 0.3 | 0.1 | 0.0 | 0.0 | — | — | — | — | 0.0 | 0.1 | 0.1 | 0.0 |
| Total Revenues | 2.5 | 1.7 | 1.2 | 0.8 | 0.3 | 0.1 | 0.0 | 0.0 | — | — | — | — | 0.0 | 0.1 | 0.1 | 0.0 |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 9.4 | 10.1 | 14.4 | 19.6 | 15.3 | 13.0 | 14.5 | 10.4 | 10.9 | 8.0 | 7.9 | 6.1 | 4.0 | 2.5 | 2.8 | 1.5 |
| Other Operating Expenses, Total | — | — | — | — | — | — | — | — | — | 0.3 | 0.5 | 0.5 | (2.3) | — | — | — |
| Operating Income | (19.4) | (21.7) | (27.0) | (36.0) | (31.8) | (28.3) | (21.2) | (16.0) | (17.9) | (14.7) | (12.4) | (10.0) | (6.0) | (4.6) | (4.1) | — |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | 0.2 | 0.1 | 0.1 | (0.1) | 0.1 | — | — | — | — | — | — |
| Other Non-Operating Income / Expenses | — | — | — | 0.3 | 1.2 | 1.3 | 0.8 | (0.1) | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — | — | — | (0.0) | (0.0) | — | — | — | — |
| Earnings from Continuing Operations | — | — | — | — | — | (26.8) | (20.4) | — | — | — | — | — | — | — | — | — |
| Net Income | ||||||||||||||||
| Minority Interest | — | — | (0.3) | (0.4) | 0.3 | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | (25.6) | (23.4) | (27.3) | (35.7) | (30.6) | (27.0) | (20.4) | (16.1) | (18.0) | (14.8) | (11.9) | (9.5) | (8.2) | (3.7) | (4.1) | (2.6) |
| Per Share | ||||||||||||||||
| Diluted EPS | (2.80) | — | (0.31) | (0.50) | — | — | — | — | — | — | — | — | — | — | — | — |
| Revenue per Share | 0.27 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 9.2 | 106.8 | 86.5 | 71.2 | — | — | — | — | — | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | (20.8) | (25.9) | (34.8) | (30.8) | (27.4) | (20.5) | (15.4) | (17.3) | (14.2) | (12.1) | (9.8) | (5.8) | (4.4) | (3.9) | — |
| EBIT | (19.4) | (21.7) | (27.0) | (36.0) | (31.8) | (28.3) | (21.2) | (16.0) | (17.9) | (14.7) | (12.4) | (10.0) | (6.0) | (4.6) | (4.1) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.